| Net income (loss) | 11.84M |
| Depreciation and amortization | 2.15M |
| Stock compensation expense | 408K |
| Provision for loan losses | -1.1M |
| Deferred tax asset valuation allowance | |
| Origination of loans for sale | -76.1M |
| Proceeds from sales of loans originated for sale | 79.09M |
| Net gains on mortgage loans | -2.24M |
| Gain on sales of securities | -99K |
| Write-down of other real estate | 774K |
| Net (gain) loss on sales of other real estate | -365K |
| Decrease (increase) in accrued interest receivable and other assets | |
| Earnings in bank-owned life insurance | -748K |
| Increase (decrease) in accrued expenses and other liabilities | 1.34M |
| Net cash from operating activities | |
| Loan originations and payments, net | |
| Purchases of securities available for sale | -72.11M |
| Maturities and calls of securities available for sale | |
| Maturities and calls of securities held to maturity | |
| Sales of securities available for sale | 9.65M |
| Principal paydowns on securities | 3.03M |
| Sales of other real estate | |
| Redemption of FHLB stock | |
| Additions to premises and equipment | -674K |
| Net cash from investing activities | |
| Net decrease in in-market deposits | -76.89M |
| Net decrease in brokered deposits | |
| Proceeds from other borrowed funds | |
| Repayments of other borrowed funds | |
| Proceeds from issuance of subordinated note | |
| Proceeds from sale of common stock, net | |
| Net cash from financing activities | |
| Net change in cash and cash equivalents | |
| Cash and cash equivalents | |
| Cash and cash equivalents | |
| Interest paid | 3.77M |
| Transfers from loans to other real estate | |